Skip to main content
Log in

Cognition in schizophrenia: from basic science to clinical treatment

  • Introduction
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321–330

    Google Scholar 

  • Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff?" Schizophr Bull 26:119–136

    Google Scholar 

  • Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL (1998) Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 155:1080–1086

    CAS  PubMed  Google Scholar 

  • Hyman SE, Fenton WS (2003) Medicine. What are the right targets for psychopharmacology? Science 299:350–351

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip D. Harvey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harvey, P.D., Geyer, M.A., Robbins, T.W. et al. Cognition in schizophrenia: from basic science to clinical treatment. Psychopharmacology 169, 213–214 (2003). https://doi.org/10.1007/s00213-003-1581-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1581-0

Keywords

Navigation